Skip to main content

Loading market data...

PEN

Penumbra, Inc.

NYSE • United states

$323.56

-$0.78

(-0.24%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Management
Credibility
Score

Penumbra, Inc. (PEN)

Unavailable

Quotes may be delayed

$12.74B

Market Cap

377,604

Volume

79.4

P/E Ratio

Unavailable

Div Yield

Penumbra, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: ONE PENUMBRA PLACE, ALAMEDA, CA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Penumbra, Inc..

31 Jul 2026

Penumbra, Inc. filed Form 10-Q

Penumbra, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

31 Jul 2026

Penumbra, Inc. reported Operating or financial results

Penumbra, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

23 Jun 2026

Penumbra, Inc. reported Shareholder voting results

Penumbra, Inc. filed an 8-K covering shareholder voting results.

7 May 2026

Penumbra, Inc. business combination filing

Penumbra, Inc. filed Form 425 (communications about a business combination).

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$205.27M

Total assets (USD)$1.97B

Total liabilities (USD)$443.96M

Shareholders' equity (USD)$1.53B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$390.05M	$41.04M	$34.81M	$0.88	10-Q · 30 Jul 2026
Q1 2026	$374.76M	$38.23M	$32.58M	$0.82	10-Q · 6 May 2026
Q4 2025	$385.39M	$59.23M	$47.34M	Unavailable	10-K · 25 Feb 2026
Q3 2025	$354.69M	$48.84M	$45.85M	$1.17	10-Q · 5 Nov 2025
Q2 2025	$339.46M	$40.83M	$45.27M	$1.15	10-Q · 29 Jul 2025
Q1 2025	$324.14M	$40.35M	$39.22M	$1.00	10-Q · 23 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Neutral

Target: $368.00

13.7% upside potential

📈

Strong Buy

Unavailable

👍

Buy

0

⏸️

Hold

4

📉

Sell

0

4 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 04:48 UTC Targets range 350.00–374.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

15

Oct 2026

Narayan Shruthi

President

Tax withholding

$321.20 per share

1,367 shares

15

Sep 2026

Narayan Shruthi

President

Tax withholding

$318.43 per share

1,230 shares

17

Aug 2026

Narayan Shruthi

President

Grant or award

Unavailable per share

3,060 shares

19

May 2026

Elsesser Adam

Director, CEO

Gift

Unavailable per share

77,000 shares

2

Apr 2026

Grewal Harpreet

Director

Open-market sale

$328.22 per share

100 shares

15

Mar 2026

Narayan Shruthi

President

Tax withholding

$336.18 per share

117 shares

15

Mar 2026

Roberts Johanna

EVP, Gen. Counsel & Secretary

Tax withholding

$336.18 per share

186 shares

15

Mar 2026

Yuen Maggie

Chief Financial Officer

Tax withholding

$336.18 per share

186 shares

Top Shareholders

Blackrock, Inc.

4,297,555 shares

-0.76% change

6/30/2026

Vanguard Group Inc

3,770,569 shares

-1.692% change

12/31/2025

Hbk Investments L P

1,838,508 shares

12.498% change

6/30/2026

Vanguard Capital Management Llc

1,709,877 shares

0.908% change

6/30/2026

Vanguard Portfolio Management Llc

1,667,276 shares

0.774% change

6/30/2026

State Street Corp

1,243,258 shares

4.845% change

6/30/2026

Exoduspoint Capital Management, Lp

1,090,430 shares

134.393% change

6/30/2026

Balyasny Asset Management L.P.

1,090,163 shares

43.048% change

6/30/2026

Jpmorgan Chase & Co

1,071,454 shares

166.121% change

6/30/2026

Goldman Sachs Group Inc

847,104 shares

17.559% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 04:48 UTC· 2 hours ago

Research coverage and investment tools

Penumbra, Inc. (PEN) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical/Dental Instruments). Its last price was US$323.56 on 21 Oct 2026. That is 72% of the way from its 52-week low of US$221.26 to its 52-week high of US$362.41. Its market capitalisation was US$12.74 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$390.05M	$41.04M	$34.81M	$0.88	67.9%	10.5%	$32.54M	10-Q · 30 Jul 2026 (opens in a new tab)
Q1 2026	$374.76M	$38.23M	$32.58M	$0.82	67.6%	10.2%	$73.30M	10-Q · 6 May 2026 (opens in a new tab)
Q4 2025	$385.39M	$59.23M	$47.34M	Unavailable	68.0%	15.4%	$68.05M	10-K · 25 Feb 2026 (opens in a new tab)
Q3 2025	$354.69M	$48.84M	$45.85M	$1.17	67.8%	13.8%	$42.01M	10-Q · 5 Nov 2025 (opens in a new tab)
Q2 2025	$339.46M	$40.83M	$45.27M	$1.15	66.0%	12.0%	$29.37M	10-Q · 29 Jul 2025 (opens in a new tab)
Q1 2025	$324.14M	$40.35M	$39.22M	$1.00	66.6%	12.4%	$35.50M	10-Q · 23 Apr 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/30/2026	$0.88	$1.15	-23.5%
Mar 2026	5/6/2026	$0.82	$1.11	-26.1%
Dec 2025	2/25/2026	$1.18	$1.12	+5.4%
Sep 2025	11/5/2025	$0.97	$0.90	+7.8%

Cash and equivalents: $205.27M
Total assets: $1.97B
Total liabilities: $443.96M
Shareholders' equity: $1.53B

SCHEDULE 13G · 14 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Penumbra, Inc..
10-Q · 31 Jul 2026

Penumbra, Inc. filed Form 10-Q (opens in a new tab)

Penumbra, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 31 Jul 2026

Penumbra, Inc. reported Operating or financial results (opens in a new tab)

Penumbra, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 23 Jun 2026

Penumbra, Inc. reported Shareholder voting results (opens in a new tab)

Penumbra, Inc. filed an 8-K covering shareholder voting results.
425 · 7 May 2026 · Merger or acquisition Announced

Penumbra, Inc. business combination filing (opens in a new tab)

Penumbra, Inc. filed Form 425 (communications about a business combination).

Insider	Date	Transaction	Shares	Average price	Filing
Narayan Shruthi President	15 Oct 2026	Tax withholding (F)	−1,367	$321.20	Form 4 (opens in a new tab)
Narayan Shruthi President	15 Sep 2026	Tax withholding (F)	−1,230	$318.43	Form 4 (opens in a new tab)
Narayan Shruthi President	17 Aug 2026	Grant or award (A)	+3,060	—	Form 4 (opens in a new tab)
Elsesser Adam Director, CEO	19 May 2026	Gift (G)	−77,000	—	Form 4 (opens in a new tab)
Grewal Harpreet Director	2 Apr 2026	Open-market sale (S)	−100	$328.22	Form 4 (opens in a new tab)
Narayan Shruthi President	15 Mar 2026	Tax withholding (F)	−117	$336.18	Form 4 (opens in a new tab)
Roberts Johanna EVP, Gen. Counsel & Secretary	15 Mar 2026	Tax withholding (F)	−186	$336.18	Form 4 (opens in a new tab)
Yuen Maggie Chief Financial Officer	15 Mar 2026	Tax withholding (F)	−186	$336.18	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	4,297,555	-0.76%
Vanguard Group Inc	12/31/2025	3,770,569	-1.692%
Hbk Investments L P	6/30/2026	1,838,508	12.498%
Vanguard Capital Management Llc	6/30/2026	1,709,877	0.908%
Vanguard Portfolio Management Llc	6/30/2026	1,667,276	0.774%
State Street Corp	6/30/2026	1,243,258	4.845%
Exoduspoint Capital Management, Lp	6/30/2026	1,090,430	134.393%
Balyasny Asset Management L.P.	6/30/2026	1,090,163	43.048%
Jpmorgan Chase & Co	6/30/2026	1,071,454	166.121%
Goldman Sachs Group Inc	6/30/2026	847,104	17.559%

Previous close: 324.34 USD
Day range: 321.97 – 324.08 USD
52-week range: 221.26 – 362.41 USD
Volume: 377,604
Market cap: $12.74B
Average volume: 312,405
P/E ratio: 79.4
EPS (FY 2025, diluted): 4.52 USD
Shares outstanding: 39.39M
Beta (5Y monthly): 0.69

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 11 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:32 UTC· 42 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for PEN yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.